MUFG Securities Americas’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
VCM
VPM
MUFG Securities Americas's MRNA Position: Q1 2026 in Review
MUFG Securities Americas increased its Moderna (MRNA) stake by 2.7% in Q1 2026, buying an estimated $11.9K and bringing the position to 9,622 shares worth $489K. The position accounts for 0.03% of the portfolio, ranked #400.
MUFG Securities Americas first reported a position in MRNA in Q4 2024 and has held it in 6 quarters since. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.
- MUFG Securities Americas held 9,622 shares of Moderna worth $489K as of Q1 2026.
- MUFG Securities Americas bought 255 Moderna shares in Q1 2026, an estimated $11.9K.
- Moderna made up 0.03% of MUFG Securities Americas's portfolio in Q1 2026, its #400 holding.
- MUFG Securities Americas first reported a position in Moderna in Q4 2024 and has held it in 6 quarters since.
- 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.
Based on MUFG Securities Americas's 13F filing for Q1 2026, filed 11 May 2026.